Breakthrough medicines are revolutionizing how we fight disease, but when red tape – like prior authorization and step therapy – delay patients’ access to these treatments, patients are unable to realize the full benefits of these medicines. Delays in treatment can lead to higher costs and harmful patient outcomes.